Immunotherapy is hailed as the new frontier in cancer treatment, and Dr. Steven Rosenberg is its pioneer. Dr. Rosenberg is the Chief of Surgery at the National Cancer Institute. One of his first surgeries, some forty years ago, involved a man whose cancer had disappeared.
“This patient had undergone one of the rarest events in all of medicine,” he says. “The spontaneous regression of a widespread cancer in the absence of any therapy. Somehow, this patient’s body had learned how to destroy his own cancer.” That case set Dr. Rosenberg off on a four decades-long investigation into the possibilities of immunotherapy, researching how to harness the body’s own ability to fight cancer.
Read More His advice following a cancer diagnosis is to seek out multiple opinions and find a doctor who is up to date with the latest information so you can make the best decisions for your treatment. Rosenberg, also dubbed “The Godfather of Immunotherapy,” was honored by the
American Association for Cancer Research with the Lifetime Achieve Award for his pioneering research that led to the first U.S. Food and Drug Administration (FDA) approved cancer immunotherapy that’s helped improve the lives of countless cancer patients worldwide. The distinguished honor came just months after Rosenberg was honored by President Biden with the
National Medal of Technology and Innovation.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Steven Rosenberg oversees the the National Cancer Institute Surgery Branch's extensive clinical program aimed at translating scientific advances into effective immunotherapies for patients with cancer. Read More